Munafa Stock Market Course + Intraday & FNO calls 
DRREDDY NEWS why is Dr. Reddy's Laboratories Limited price falling or rising
DRREDDY NEWS reasons for why stock price of Dr. Reddy's Laboratories Limited is falling or rising
DRREDDY Dr Reddy is falling or rising technical reasons
Technical analysis forecast of Dr Reddy Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Dr Reddy DRREDDY at this time. Stock is rising and might rise more.
It appears as if Dr Reddy DRREDDY gave a large move recently.
Stock of Dr Reddy (DRREDDY) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Dr Reddy is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Dr Reddy stays above 1281.5, but if it comes below 1281.5, then a intra day sell could be more profitable.
If you take a sell trade below 1281.5, then use 1281.5 as stoploss and 1267.47 as target. However if you take a buy trade in Dr Reddy, then use 1281.5 as stoploss and 1298.3 as target.
DRREDDY Dr Reddy is falling or rising NEWS fundamental reasons
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2025-12-18
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet - NEWS as on 2025-12-16
Company Announcement - NEWS as on 2025-12-11
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates - NEWS as on 2025-12-10
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up - NEWS as on 2025-12-08
Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug Dr. Reddy's Laboratories has secured an exclusive licensing agreement with Immutep to manufacture, develop, and distribute the Australian company's cancer therapy, eftilagimod alfa. This significant deal, valued at up to 0 million, grants Dr. Reddy's di - NEWS as on 2025-12-08 indiatimes.com
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 24, 2025, titled "Dr. Reddy s receives European Commission approval for AVT03 (denosumab), a proposed Biosimilar of Prolia® and Xgeva®". - NEWS as on 2025-11-24
More announcements and NEWS
DRREDDY Dr. Reddy's Laboratories Limited current price & indicator signals
Recent prices of DRREDDY Dr. Reddy's Laboratories Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Mon Dec 2025 | 1283.40 | 1276.70 to 1286.30 | 0.41% | 0.48 times |
| 19 Fri Dec 2025 | 1278.20 | 1268.90 to 1292.90 | -0.14% | 0.94 times |
| 18 Thu Dec 2025 | 1280.00 | 1262.00 to 1283.90 | 0.63% | 0.69 times |
| 17 Wed Dec 2025 | 1272.00 | 1267.30 to 1281.00 | -0.38% | 0.69 times |
| 16 Tue Dec 2025 | 1276.90 | 1272.00 to 1285.90 | -0.29% | 0.72 times |
| 15 Mon Dec 2025 | 1280.60 | 1264.10 to 1282.80 | 0.1% | 0.83 times |
| 12 Fri Dec 2025 | 1279.30 | 1267.30 to 1280.40 | 0.46% | 0.76 times |
| 11 Thu Dec 2025 | 1273.50 | 1248.00 to 1275.90 | 1.81% | 1.33 times |
| 10 Wed Dec 2025 | 1250.80 | 1246.80 to 1262.10 | 0.37% | 1.29 times |
| 09 Tue Dec 2025 | 1246.20 | 1241.30 to 1267.40 | -1.6% | 1.64 times |
| 08 Mon Dec 2025 | 1266.50 | 1263.70 to 1279.00 | -0.68% | 1.11 times |
| 05 Fri Dec 2025 | 1275.20 | 1271.60 to 1282.80 | -0.19% | 0.8 times |
Videos related to: DRREDDY NEWS why is Dr. Reddy's Laboratories Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
